271 related articles for article (PubMed ID: 34332016)
1. Restoring lost nigrostriatal fibers in Parkinson's disease based on clinically-inspired design criteria.
Gordián-Vélez WJ; Chouhan D; España RA; Chen HI; Burdick JA; Duda JE; Cullen DK
Brain Res Bull; 2021 Oct; 175():168-185. PubMed ID: 34332016
[TBL] [Abstract][Full Text] [Related]
2. Axonal Tract Reconstruction Using a Tissue-Engineered Nigrostriatal Pathway in a Rat Model of Parkinson's Disease.
Struzyna LA; Browne KD; Burrell JC; Vélez WJG; Wofford KL; Kaplan HM; Murthy NS; Chen HI; Duda JE; España RA; Cullen DK
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430464
[TBL] [Abstract][Full Text] [Related]
3. Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease.
Struzyna LA; Browne KD; Brodnik ZD; Burrell JC; Harris JP; Chen HI; Wolf JA; Panzer KV; Lim J; Duda JE; España RA; Cullen DK
J Tissue Eng Regen Med; 2018 Jul; 12(7):1702-1716. PubMed ID: 29766664
[TBL] [Abstract][Full Text] [Related]
4. Reversing a model of Parkinson's disease with in situ converted nigral neurons.
Qian H; Kang X; Hu J; Zhang D; Liang Z; Meng F; Zhang X; Xue Y; Maimon R; Dowdy SF; Devaraj NK; Zhou Z; Mobley WC; Cleveland DW; Fu XD
Nature; 2020 Jun; 582(7813):550-556. PubMed ID: 32581380
[TBL] [Abstract][Full Text] [Related]
5. Emerging regenerative medicine and tissue engineering strategies for Parkinson's disease.
Harris JP; Burrell JC; Struzyna LA; Chen HI; Serruya MD; Wolf JA; Duda JE; Cullen DK
NPJ Parkinsons Dis; 2020; 6():4. PubMed ID: 31934611
[TBL] [Abstract][Full Text] [Related]
6. Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants.
Mendez I; Sadi D; Hong M
J Neurosci; 1996 Nov; 16(22):7216-27. PubMed ID: 8929430
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic Axons: Key Recitalists in Parkinson's Disease.
Mishra AK; Dixit A
Neurochem Res; 2022 Feb; 47(2):234-248. PubMed ID: 34637100
[TBL] [Abstract][Full Text] [Related]
8. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
[TBL] [Abstract][Full Text] [Related]
9. Function and Regulation of ALDH1A1-Positive Nigrostriatal Dopaminergic Neurons in Motor Control and Parkinson's Disease.
Carmichael K; Evans RC; Lopez E; Sun L; Kumar M; Ding J; Khaliq ZM; Cai H
Front Neural Circuits; 2021; 15():644776. PubMed ID: 34079441
[TBL] [Abstract][Full Text] [Related]
10. Axon responses of embryonic stem cell-derived dopaminergic neurons to semaphorins 3A and 3C.
Tamariz E; Díaz-Martínez NE; Díaz NF; García-Peña CM; Velasco I; Varela-Echavarría A
J Neurosci Res; 2010 Apr; 88(5):971-80. PubMed ID: 19859963
[TBL] [Abstract][Full Text] [Related]
11. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
12. Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice.
Hwang DY; Ardayfio P; Kang UJ; Semina EV; Kim KS
Brain Res Mol Brain Res; 2003 Jun; 114(2):123-31. PubMed ID: 12829322
[TBL] [Abstract][Full Text] [Related]
13. Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease.
Caminiti SP; Presotto L; Baroncini D; Garibotto V; Moresco RM; Gianolli L; Volonté MA; Antonini A; Perani D
Neuroimage Clin; 2017; 14():734-740. PubMed ID: 28409113
[TBL] [Abstract][Full Text] [Related]
14. Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum.
Matsuda W; Furuta T; Nakamura KC; Hioki H; Fujiyama F; Arai R; Kaneko T
J Neurosci; 2009 Jan; 29(2):444-53. PubMed ID: 19144844
[TBL] [Abstract][Full Text] [Related]
15. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
Nordströma U; Beauvais G; Ghosh A; Pulikkaparambil Sasidharan BC; Lundblad M; Fuchs J; Joshi RL; Lipton JW; Roholt A; Medicetty S; Feinstein TN; Steiner JA; Escobar Galvis ML; Prochiantz A; Brundin P
Neurobiol Dis; 2015 Jan; 73():70-82. PubMed ID: 25281317
[TBL] [Abstract][Full Text] [Related]
16. The nigrostriatal pathway: axonal collateralization and compartmental specificity.
Prensa L; Giménez-Amaya JM; Parent A; Bernácer J; Cebrián C
J Neural Transm Suppl; 2009; (73):49-58. PubMed ID: 20411767
[TBL] [Abstract][Full Text] [Related]
17. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
Bentlage C; Nikkhah G; Cunningham MG; Björklund A
Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
[TBL] [Abstract][Full Text] [Related]
18. Human Stem Cell-Derived Neurons Repair Circuits and Restore Neural Function.
Xiong M; Tao Y; Gao Q; Feng B; Yan W; Zhou Y; Kotsonis TA; Yuan T; You Z; Wu Z; Xi J; Haberman A; Graham J; Block J; Zhou W; Chen Y; Zhang SC
Cell Stem Cell; 2021 Jan; 28(1):112-126.e6. PubMed ID: 32966778
[TBL] [Abstract][Full Text] [Related]
19. Adult neurogenesis and Parkinson's disease.
Arias-Carrión O; Freundlieb N; Oertel WH; Höglinger GU
CNS Neurol Disord Drug Targets; 2007 Oct; 6(5):326-35. PubMed ID: 18045161
[TBL] [Abstract][Full Text] [Related]
20. Chondroitinase improves midbrain pathway reconstruction by transplanted dopamine progenitors in Parkinsonian mice.
Kauhausen JA; Thompson LH; Parish CL
Mol Cell Neurosci; 2015 Nov; 69():22-9. PubMed ID: 26463051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
